References

  1. Young Barbara, Heath John W. Wheater's Functional Histology (4th ed). 2000. London, England. Churchill Livingstone.

  2. The Histiocyte Society. Welcome to our Society. 2011. Available from: http://www.histiocytesociety.org. viewed August 2013.

  3. Gadner H, Grois N. Histiocytosis Syndromes, in Fitzpatrick TB, Elsen AZ, Wolff K, et al, eds. Dermatology in General Medicine, 4th ed. 199 New York, McGraw-Hill Inc. PubMed | Google Scholar

  4. Willman CL, Busque l, Griffith BB. Langerhans’ cell histiocytosis (Histiocytosis X): a clonal proliferative disease. N Engl J Med 1994 Jul 21;331(3):154-60. Google Scholar

  5. Foss HD, Herbst H, Araujo I, Thomas C, Fraitag S, Prost Y, Brousse N. Monokine expression in Langerhans’ cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Pathol. 1996 May;179(1):60-5. PubMed | Google Scholar

  6. Mcclain K, Jin H, Gresik V, Favara B. Langerhans’ cell histiocytosis. Lack of a viral etiology. Am J Hematol. 1994 Sep;47(1):16-20. PubMed | Google Scholar

  7. Broadbent V, Pritchard J, Davies EG, et al. Spontaneous remission of multi-system histiocytosis X. Lancet. 1984 Feb 4;1(8371):253-4. PubMed | Google Scholar

  8. De Filippi P, Badulli C, Cuccia M, et al.: Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br J Haematol. 2006;132 (6): 784-7. PubMed | Google Scholar

  9. Axiotis CA, Merino JM, Duray PH. Langerhans cell histiocytosis of the female genital tract. Cancer. 1991 Mar 15;67(6):1650-60. PubMed | Google Scholar

  10. Verret JL, Hadet M, Brunet A, Elnekave FL, Avenel M. Histiocytose X avecgranulomee´osinophilepe´rianovulvaire. Effet favorable des applications locales de moustarde a l’azotesurlc`sionsanovulvaires. Ann Dermatol Venereol. 1985;112(2):165-6. PubMed | Google Scholar

  11. Sander CS, Kaatz M, Elsner P. Successful treatment of cutaneous Langerhans cell histiocytosis with thalidomide. Dermatology. 2004;208(2):149-52. PubMed | Google Scholar

  12. Li R, Lin T, Gu H, Zhou Z. Successful thalidomide treatment of adult solitary perianal Langerhans cell histiocytosis. Eur J Dermatol. 2010 May-Jun;20(3):391-2. PubMed | Google Scholar

  13. Lair G, Marie I, Cailleux N, Blot E, Bouillié MC, Courville P, et al. Histiocytose langerhansienne de l’adulte : localisationscutanéomuqueuses régressives après traitement par thalidomide. Rev Med Interne. 1998 Mar;19(3):196-8. PubMed | Google Scholar

  14. Meunier L, Marck Y, Ribeyre C, Meynadier J. Adulte cutaneous Langerhans cellhistiocytosis: remission with thalidomide treatment. Br J Dermatol. 1995 Jan;132(1):168. PubMed | Google Scholar